Global Intravitreal Injectable Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Intravitreal Injectable market size will reach 18,879 Million USD in 2025 and is projected to reach 31,465 Million USD by 2032, with a CAGR of 7.57% (2025-2032). Notably, the China Intravitreal Injectable market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An intravitreal injectable is a medication administered directly into the vitreous cavity of the eye, which is the gel-like substance that fills the space between the lens and the retina. This injection is typically performed to deliver therapeutic agents for the treatment of various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and macular edema. Common intravitreal injectables include anti-vascular endothelial growth factor (anti-VEGF) drugs, steroids, or other agents designed to address specific pathological processes within the eye. The injection is usually done in an outpatient setting, and the procedure helps to achieve a high concentration of the medication at the target site, minimizing systemic side effects. Intravitreal injectables have become a standard and effective approach in the management of retinal disorders, contributing to improved visual outcomes and preventing further progression of certain eye diseases.
The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Intravitreal Injectable. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravitreal Injectable market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Intravitreal Injectable market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravitreal Injectable industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Intravitreal Injectable Include:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Intravitreal Injectable Product Segment Include:
Anti-VEGF
Steroids
Others
Intravitreal Injectable Product Application Include:
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Intravitreal Injectable Industry PESTEL Analysis
Chapter 3: Global Intravitreal Injectable Industry Porter's Five Forces Analysis
Chapter 4: Global Intravitreal Injectable Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Intravitreal Injectable Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Intravitreal Injectable Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Intravitreal Injectable Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Intravitreal Injectable market size will reach 18,879 Million USD in 2025 and is projected to reach 31,465 Million USD by 2032, with a CAGR of 7.57% (2025-2032). Notably, the China Intravitreal Injectable market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
An intravitreal injectable is a medication administered directly into the vitreous cavity of the eye, which is the gel-like substance that fills the space between the lens and the retina. This injection is typically performed to deliver therapeutic agents for the treatment of various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and macular edema. Common intravitreal injectables include anti-vascular endothelial growth factor (anti-VEGF) drugs, steroids, or other agents designed to address specific pathological processes within the eye. The injection is usually done in an outpatient setting, and the procedure helps to achieve a high concentration of the medication at the target site, minimizing systemic side effects. Intravitreal injectables have become a standard and effective approach in the management of retinal disorders, contributing to improved visual outcomes and preventing further progression of certain eye diseases.
The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Intravitreal Injectable. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravitreal Injectable market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Intravitreal Injectable market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravitreal Injectable industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Intravitreal Injectable Include:
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Intravitreal Injectable Product Segment Include:
Anti-VEGF
Steroids
Others
Intravitreal Injectable Product Application Include:
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Intravitreal Injectable Industry PESTEL Analysis
Chapter 3: Global Intravitreal Injectable Industry Porter's Five Forces Analysis
Chapter 4: Global Intravitreal Injectable Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Intravitreal Injectable Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Intravitreal Injectable Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Intravitreal Injectable Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Intravitreal Injectable Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Intravitreal Injectable Product by Type
- 1.2.1 Anti-VEGF
- 1.2.2 Steroids
- 1.2.3 Others
- 1.3 Intravitreal Injectable Product by Application
- 1.3.1 Macular Degeneration
- 1.3.2 Macular Edema
- 1.3.3 Uveitis
- 1.3.4 Retinal Vein Occlusion
- 1.3.5 Others
- 1.4 Global Intravitreal Injectable Market Revenue and Sales Analysis
- 1.4.1 Global Intravitreal Injectable Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Intravitreal Injectable Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Intravitreal Injectable Market Sales Price Trend Analysis (2020-2032)
- 1.5 Intravitreal Injectable Market Development Status and Trends
- 1.5.1 Intravitreal Injectable Industry Development Status Analysis
- 1.5.2 Intravitreal Injectable Industry Development Trends Analysis
- 2 Intravitreal Injectable Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Intravitreal Injectable Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Intravitreal Injectable Market Analysis by Country
- 4.1 Global Intravitreal Injectable Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Intravitreal Injectable Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Intravitreal Injectable Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Intravitreal Injectable Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Intravitreal Injectable Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Intravitreal Injectable Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Intravitreal Injectable Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Intravitreal Injectable Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Intravitreal Injectable Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Intravitreal Injectable Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Intravitreal Injectable Average Sales Price by Manufacturers (2021-2025)
- 5.2 Intravitreal Injectable Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Intravitreal Injectable Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Intravitreal Injectable Market Analysis by Type
- 6.1 Global Intravitreal Injectable Market Revenue Analysis by Type
- 6.1.1 Global Intravitreal Injectable Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Intravitreal Injectable Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Intravitreal Injectable Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Intravitreal Injectable Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Regeneron Pharmaceuticals (Eylea)
- 7.1.1 Regeneron Pharmaceuticals (Eylea) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
- 7.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Allergan
- 7.2.1 Allergan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Allergan Intravitreal Injectable Product Portfolio
- 7.2.3 Allergan Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 EyePoint Pharmaceuticals
- 7.3.1 EyePoint Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
- 7.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Genentech
- 7.4.1 Genentech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Genentech Intravitreal Injectable Product Portfolio
- 7.4.3 Genentech Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Kanghong Pharmaceutical
- 7.5.1 Kanghong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
- 7.5.3 Kanghong Pharmaceutical Intravitreal Injectable Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Intravitreal Injectable Industry Chain Analysis
- 8.2 Intravitreal Injectable Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Intravitreal Injectable Product Downstream Application Analysis
- 8.3.1 Global Intravitreal Injectable Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Intravitreal Injectable Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Intravitreal Injectable Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Intravitreal Injectable Typical Downstream Customers
- 8.5 Intravitreal Injectable Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.